Keyphrases
Tuberculosis Patients
100%
Indonesia
79%
Multidrug-resistant Tuberculosis (MDR-TB)
64%
Mycobacterium Tuberculosis (M. tb)
60%
Pulmonary Tuberculosis
54%
Tuberculosis
53%
Surabaya
40%
Antibacterial Activity
30%
COVID-19
27%
Bedaquiline
23%
Rifampicin
21%
Risk Factors
19%
TB Patients
19%
Rifampicin-resistant Tuberculosis
19%
Indonesian
18%
Sputum
17%
Acid-fast Bacilli
16%
QTc Interval
14%
Tuberculosis Treatment
14%
Passiflora Edulis Sims
13%
Tuberculosis Diagnosis
13%
Active Tuberculosis
12%
Tertiary Referral Hospital
12%
Type 1 Diabetes Mellitus (T1DM)
11%
Shorter Regimen
11%
Referral Hospital
11%
Xpert MTB
11%
Escherichia Coli
11%
Rifampicin Resistance
11%
QT Prolongation
11%
Intensive Phase
10%
Pulmonary TB Patients
10%
C-reactive Protein
10%
Delamanid
10%
Medical Records
9%
Red Passion Fruit
9%
Culture Method
9%
Multidrug-resistant
9%
Clinical Outcomes
9%
N-acetyltransferase 2 (NAT2)
9%
East Java Indonesia
8%
Sputum Samples
8%
Anti-tuberculosis Drugs
8%
Lung Damage
8%
Chest X-ray
8%
Treatment Outcome
8%
Mycobacterium
8%
Moxifloxacin
8%
Inhibitory Activity
7%
Academic Hospital
7%
General Hospital
7%
Latent Tuberculosis Infection
7%
Antibiotics
7%
Lactic Acid Bacteria
7%
Methicillin-resistant Staphylococcus Aureus
7%
GeneXpert
7%
Xpert
7%
Ag85B
7%
Staphylococcus Aureus
6%
Minimum Inhibitory Concentration
6%
Aqueous Extract
6%
Saccharum Officinarum
6%
Pneumonia Patients
6%
Population Pharmacokinetic Model
6%
Jember
6%
Cloning Expression
6%
Short-term Treatment
6%
Healthcare Workers
6%
Peripheral Blood Mononuclear Cells
6%
Inflammatory Cytokines
6%
Potential Biomarkers
6%
Fine-needle Aspiration Biopsy
6%
Antimicrobial Activity
6%
Extended-spectrum beta-lactamase-producing Escherichia Coli
6%
Lung Tissue Damage
6%
Multidrug-resistant Organisms
6%
Indonesian Patients
6%
Radiological Diagnosis
6%
Lung Tuberculosis
6%
Streptomyces Sp.
6%
Cell-free
6%
Continuation Phase
6%
Drug-resistant Pulmonary Tuberculosis
6%
Pneumonia
6%
Antibacterial Agents
5%
Treatment Regimen
5%
16S Ribosomal RNA (16S rRNA)
5%
Fermentation
5%
Polymerase Chain Reaction
5%
Culture Results
5%
Streptomycin
5%
Healthy Controls
5%
Smear Positive
5%
Staphylococcus Aureus ATCC 25923
5%
Sugarcane Bagasse
5%
MGIT 960
5%
Pharmacology, Toxicology and Pharmaceutical Science
Lung Tuberculosis
46%
Mycobacterium Tuberculosis
40%
Drug Resistant Tuberculosis
40%
Diseases
33%
Rifampicin
32%
Bedaquiline
23%
Antibacterial Activity
22%
Multi-Drug-Resistant Tuberculosis
21%
Tuberculosis
17%
Antiinfective Agent
14%
Side Effect
14%
Coronavirinae
13%
Escherichia coli
12%
Acid Fast Bacterium
11%
Infectious Agent
10%
Infection
10%
Staphylococcus Aureus
10%
Cross-Sectional Study
10%
Streptomyces
10%
Passiflora edulis
10%
Delamanid
10%
Pharmacokinetics
9%
Retrospective Study
9%
Moxifloxacin
8%
Lung Injury
8%
Flavonoid
7%
Microorganism
7%
Latent Tuberculosis
7%
Extended Spectrum Beta Lactamase
7%
Prevalence
6%
Tuberculostatic Agent
6%
Mycobacteria
6%
Hibiscus sabdariffa
6%
C Reactive Protein
6%
Cytokine
6%
Adenosine Deaminase
6%
Tissue Injury
6%
Coconut
6%
Extrapulmonary Tuberculosis
6%
Antimicrobial Agent
6%
Antibiotics
6%
Diabetes Mellitus
6%
Pharmacotherapy
6%
Tumor Necrosis Factor
6%
Atypical Mycobacterium
5%
Minimum Inhibitory Concentration
5%
Isoniazid
5%
Comorbidity
5%
Medicine and Dentistry
Lung Tuberculosis
32%
COVID-19
27%
Mycobacterium Tuberculosis
23%
Sputum
22%
Drug Resistant Tuberculosis
20%
Diseases
14%
Rifampicin
13%
Multidrug Resistant Tuberculosis
12%
Acid Fast Bacterium
11%
Bedaquiline
10%
Diagnosis
10%
Severe Acute Respiratory Syndrome Coronavirus 2
9%
Patient Referral
8%
Tuberculostatic Agent
8%
Extrapulmonary Tuberculosis
8%
Mixed Infection
7%
Tuberculosis
7%
Diabetes Mellitus
7%
Infection
7%
C Reactive Protein
6%
Adenosine Deaminase
6%
Systematic Review
6%
Delamanid
6%
Sputum Culture
6%
Cross Sectional Study
5%
Medical Record
5%
Lung
5%
Fine-Needle Aspiration
5%
Retrospective Study
5%
Polymerase Chain Reaction
5%
Culture Conversion
5%